GB8506869D0 - Antiviral compound - Google Patents

Antiviral compound

Info

Publication number
GB8506869D0
GB8506869D0 GB858506869A GB8506869A GB8506869D0 GB 8506869 D0 GB8506869 D0 GB 8506869D0 GB 858506869 A GB858506869 A GB 858506869A GB 8506869 A GB8506869 A GB 8506869A GB 8506869 D0 GB8506869 D0 GB 8506869D0
Authority
GB
United Kingdom
Prior art keywords
antiviral compound
antiviral
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB858506869A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB858506869A priority Critical patent/GB8506869D0/en
Publication of GB8506869D0 publication Critical patent/GB8506869D0/en
Priority to US06/776,899 priority patent/US4724232A/en
Priority to DK118086A priority patent/DK164392C/da
Priority to DE19863608606 priority patent/DE3608606A1/de
Priority to IE67686A priority patent/IE73219B1/en
Priority to FI902941A priority patent/FI902941A7/fi
Priority to AU54758/86A priority patent/AU572019B2/en
Priority to PH33532A priority patent/PH24388A/en
Priority to DE198686301897T priority patent/DE196185T1/de
Priority to IE210/88A priority patent/IE56505B1/en
Priority to IL78158A priority patent/IL78158A/xx
Priority to AT86301896T priority patent/ATE135011T1/de
Priority to KR1019860001836A priority patent/KR860006987A/ko
Priority to MC861828A priority patent/MC1742A1/xx
Priority to APAP/P/1986/000027A priority patent/AP11A/en
Priority to HU874087A priority patent/HU199501B/hu
Priority to ES553013A priority patent/ES8800257A1/es
Priority to EP86301897A priority patent/EP0196185B1/en
Priority to IL8509686A priority patent/IL85096A/en
Priority to DE3650492T priority patent/DE3650492T2/de
Priority to EP88101795A priority patent/EP0306597B2/en
Priority to EP88101790A priority patent/EP0291633B1/en
Priority to AT88101795T priority patent/ATE113603T1/de
Priority to PT82199A priority patent/PT82199B/pt
Priority to IE677/86A priority patent/IE56503B1/en
Priority to AU54757/86A priority patent/AU578809B2/en
Priority to DE8686301897T priority patent/DE3664257D1/de
Priority to DE8888101790T priority patent/DE3687069T2/de
Priority to IE209/88A priority patent/IE56504B1/en
Priority to NZ22400786A priority patent/NZ224007A/en
Priority to GR860712A priority patent/GR860712B/el
Priority to AT86301897T priority patent/ATE44464T1/de
Priority to PH33532A priority patent/PH27190A/en
Priority to HU861079A priority patent/HU197209B/hu
Priority to DE3650130T priority patent/DE3650130T3/de
Priority to CY1508A priority patent/CY1508A/xx
Priority to FI861069A priority patent/FI85978C/fi
Priority to AT88101790T priority patent/ATE81978T1/de
Priority to NZ215486A priority patent/NZ215486A/xx
Priority to EP86301896A priority patent/EP0199451B1/en
Priority to AT0068386A priority patent/AT390000B/de
Priority to CA000504095A priority patent/CA1285935C/en
Priority to ZA861933A priority patent/ZA861933B/xx
Priority to CA000504126A priority patent/CA1238277A/en
Priority to DK118286A priority patent/DK166805B1/da
Priority to JP61059072A priority patent/JPS61257925A/ja
Priority to JP5907386A priority patent/JPH0723314B2/ja
Priority to US06/899,079 priority patent/US5683990A/en
Priority to ES557209A priority patent/ES8802469A1/es
Priority to US06/945,234 priority patent/US4780453A/en
Priority to AT88987A priority patent/AT392794B/de
Priority to PH35502A priority patent/PH24360A/en
Priority to PH35500A priority patent/PH26994A/en
Priority to MYPI87001943A priority patent/MY102693A/en
Priority to US07/110,377 priority patent/US4837208A/en
Priority to US07/110,946 priority patent/US4833130A/en
Priority to US07/111,205 priority patent/US4818538A/en
Priority to US07/111,208 priority patent/US4828838A/en
Priority to IL85096A priority patent/IL85096A0/xx
Priority to IL85095A priority patent/IL85095A0/xx
Priority to CA000556981A priority patent/CA1303032C/en
Priority to US07/153,258 priority patent/US4874609A/en
Priority to AU12158/88A priority patent/AU574620B1/en
Priority to AU12159/88A priority patent/AU587739B2/en
Priority to JP63073488A priority patent/JPH0780898B2/ja
Priority to ES557834A priority patent/ES8802467A1/es
Priority to ES557835A priority patent/ES8802615A1/es
Priority to ES557836A priority patent/ES8802616A1/es
Priority to MYPI88001437A priority patent/MY104069A/en
Priority to SG628/89A priority patent/SG62889G/en
Priority to HK857/89A priority patent/HK85789A/en
Priority to US07/622,396 priority patent/US5093114A/en
Priority to CS913851A priority patent/CS385191A3/cs
Priority to DK199102026A priority patent/DK175122B1/da
Priority to DK199102027A priority patent/DK175192B1/da
Priority to CA000616284A priority patent/CA1340519C/en
Priority to US08/005,405 priority patent/US5643891A/en
Priority to LV950243A priority patent/LV5724B4/xx
Priority to HK164395A priority patent/HK164395A/en
Priority to CY188996A priority patent/CY1889A/xx
Priority to US08/882,888 priority patent/US5885957A/en
Priority to US08/889,254 priority patent/US5877163A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB858506869A 1985-03-16 1985-03-16 Antiviral compound Pending GB8506869D0 (en)

Priority Applications (82)

Application Number Priority Date Filing Date Title
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound
US06/776,899 US4724232A (en) 1985-03-16 1985-09-17 Treatment of human viral infections
DK118086A DK164392C (da) 1985-03-16 1986-03-14 Anvendelse af 3'-azido-3'-desoxythymidin til fremstilling af et laegemiddel til behandling af eller profylakse for en human retrovirusinfektion
DE19863608606 DE3608606A1 (de) 1985-03-16 1986-03-14 3'-azido-3'-deoxythymidin oder eine, ein pharmazeutisch vertraegliches derivat davon enthaltende pharmazeutische formulierung, verfahren zu ihrer herstellung und ihre verwendung
IE67686A IE73219B1 (en) 1985-03-16 1986-03-14 Therapeutic nucleosides
FI902941A FI902941A7 (fi) 1985-03-16 1986-03-14 Menetelmä faramaseuttisen valmisteen valmistamiseksi
AU54758/86A AU572019B2 (en) 1985-03-16 1986-03-14 3'-azido-3'-deoxythymidine
PH33532A PH24388A (en) 1985-03-16 1986-03-14 Antiviral nucleosides
DE198686301897T DE196185T1 (de) 1985-03-16 1986-03-14 Antivirale nukleoside.
IE210/88A IE56505B1 (en) 1985-03-16 1986-03-14 Antiviral nucleosides
IL78158A IL78158A (en) 1985-03-16 1986-03-14 Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine
AT86301896T ATE135011T1 (de) 1985-03-16 1986-03-14 Therapeutische nukleoside
KR1019860001836A KR860006987A (ko) 1985-03-16 1986-03-14 항 비루스성 뉴클레오시드의 제조방법 및 이것을 함유한 약학적 제형 제조방법
MC861828A MC1742A1 (fr) 1985-03-16 1986-03-14 Procede pour preparer un derive de 3'-azido-3'desoxythymigline et procede pour preparer une formulation pharmaceutique le contenant
APAP/P/1986/000027A AP11A (en) 1985-03-16 1986-03-14 Antiviral nucleosides.
HU874087A HU199501B (en) 1985-03-16 1986-03-14 Process for producing 3'-azido-3'-deoxytimidine-5' ester derivatives and pharmaceutical compositions comprising the same
ES553013A ES8800257A1 (es) 1985-03-16 1986-03-14 Un procedimiento para preparar sales o esteres farmaceuticamente aceptables de 3'-azido-3'-dexositimidina.
EP86301897A EP0196185B1 (en) 1985-03-16 1986-03-14 Antiviral nucleosides
IL8509686A IL85096A (en) 1985-03-16 1986-03-14 Use of 3'-azido-3'- deoxythymidine in the treatment of prophylaxis of human retrovirus infection
DE3650492T DE3650492T2 (de) 1985-03-16 1986-03-14 Therapeutische Nukleoside
EP88101795A EP0306597B2 (en) 1985-03-16 1986-03-14 Antiviral nucleosides
EP88101790A EP0291633B1 (en) 1985-03-16 1986-03-14 Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections
AT88101795T ATE113603T1 (de) 1985-03-16 1986-03-14 Antivirale nukleoside.
PT82199A PT82199B (pt) 1985-03-16 1986-03-14 Processo para a preparacao de nucleosidos antivirais e de composicoes farmaceuticas que os contem
IE677/86A IE56503B1 (en) 1985-03-16 1986-03-14 Antiviral nucleosides
AU54757/86A AU578809B2 (en) 1985-03-16 1986-03-14 Therapeutic nucleosides
DE8686301897T DE3664257D1 (en) 1985-03-16 1986-03-14 Antiviral nucleosides
DE8888101790T DE3687069T2 (de) 1985-03-16 1986-03-14 Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
IE209/88A IE56504B1 (en) 1985-03-16 1986-03-14 Antiviral nucleosides
NZ22400786A NZ224007A (en) 1985-03-16 1986-03-14 3'-azido-3'-deoxythymidine derivatives as antiviral agents
GR860712A GR860712B (en) 1985-03-16 1986-03-14 Antiviral compounds
AT86301897T ATE44464T1 (de) 1985-03-16 1986-03-14 Antivirale nukleoside.
PH33532A PH27190A (en) 1985-03-16 1986-03-14 Antiviral nucleosides
HU861079A HU197209B (en) 1985-03-16 1986-03-14 Process for producing pharmaceutical compositions containing 3'-azido-3'-deoxytimidine of antiviral activity againt human retrovirus
DE3650130T DE3650130T3 (de) 1985-03-16 1986-03-14 Antivirale Nukleoside.
CY1508A CY1508A (en) 1985-03-16 1986-03-14 Antiviral nucleosides
FI861069A FI85978C (fi) 1985-03-16 1986-03-14 Foerfarande foer framstaellning av ett terapeutiskt anvaendbart salt eller ester av 3'-azido-3'deoxitymidin.
AT88101790T ATE81978T1 (de) 1985-03-16 1986-03-14 Verwendung von 3'-azido-3'-deoxythymidin zur behandlung oder vorbeugung von menschlichen retrovirus-infektionen.
NZ215486A NZ215486A (en) 1985-03-16 1986-03-14 3'-azido-3'-deoxythymidine antiretroviral compositions (zidovudine, azt)
EP86301896A EP0199451B1 (en) 1985-03-16 1986-03-14 Therapeutic nucleosides
AT0068386A AT390000B (de) 1985-03-16 1986-03-14 Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
CA000504095A CA1285935C (en) 1985-03-16 1986-03-14 Therapeutic nucleosides
ZA861933A ZA861933B (en) 1985-03-16 1986-03-14 Antiviral nucleosides
CA000504126A CA1238277A (en) 1985-03-16 1986-03-14 Antiviral nucleosides
DK118286A DK166805B1 (da) 1985-03-16 1986-03-14 Threo-isomeren af 3'-azido-3'-deoxythymidin til anvendelse ved behandling af eller profylakse for humane retrovirusinfektioner, anvendelse af forbindelsen til fremstilling af et laegemiddel med naevnte indikation og farmaceutisk praeparat indeholdende forbindelsen
JP61059072A JPS61257925A (ja) 1985-03-16 1986-03-17 抗ウイルスヌクレオシド
JP5907386A JPH0723314B2 (ja) 1985-03-16 1986-03-17 治療用ヌクレオシド
US06/899,079 US5683990A (en) 1985-03-16 1986-08-21 Treatment of human viral infections
ES557209A ES8802469A1 (es) 1985-03-16 1986-11-18 Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
US06/945,234 US4780453A (en) 1985-03-16 1986-12-23 Treatment of feline viral infections
AT88987A AT392794B (de) 1985-03-16 1987-04-09 Verfahren zur herstellung von neuen pharmazeutisch annehmbaren estern und salzen von 3'-azido-3'-desoxythymidin
PH35502A PH24360A (en) 1985-03-16 1987-07-02 Antiviral nucleosides
PH35500A PH26994A (en) 1985-03-16 1987-07-06 Antiviral nucleosides
MYPI87001943A MY102693A (en) 1985-03-16 1987-09-25 Antiviral nucleosides
US07/110,377 US4837208A (en) 1985-03-16 1987-10-20 Treatment of human viral infections
US07/110,946 US4833130A (en) 1985-03-16 1987-10-20 Treatment of human viral infections
US07/111,205 US4818538A (en) 1985-03-16 1987-10-21 Treatment of human viral infections
US07/111,208 US4828838A (en) 1985-03-16 1987-10-21 Treatment of human viral infection
IL85096A IL85096A0 (en) 1985-03-16 1988-01-13 Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retrovirus infection
IL85095A IL85095A0 (en) 1985-03-16 1988-01-13 Pharmaceutical compositions containing 3'-azido-3'-deoxythymidine derivatives,certain such novel compounds and their preparation
CA000556981A CA1303032C (en) 1985-03-16 1988-01-20 Antiviral nucleosides
US07/153,258 US4874609A (en) 1985-03-16 1988-02-08 Treatment of human viral infections
AU12158/88A AU574620B1 (en) 1985-03-16 1988-02-24 Use of 3'-azido-3'-deoxythymidine
AU12159/88A AU587739B2 (en) 1985-03-16 1988-02-24 Derivatives of 3'-azido-3'-deoxythymidine
JP63073488A JPH0780898B2 (ja) 1985-03-16 1988-03-29 抗ウイルスヌクレオシド
ES557834A ES8802467A1 (es) 1985-03-16 1988-04-29 Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
ES557835A ES8802615A1 (es) 1985-03-16 1988-04-29 Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
ES557836A ES8802616A1 (es) 1985-03-16 1988-04-29 Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
MYPI88001437A MY104069A (en) 1985-03-16 1988-12-12 Therapeutic nucleosides
SG628/89A SG62889G (en) 1985-03-16 1989-09-11 Antiviral nucleosides
HK857/89A HK85789A (en) 1985-03-16 1989-10-26 Antiviral nucleosides
US07/622,396 US5093114A (en) 1985-03-16 1990-11-30 Treatment of human viral infections
CS913851A CS385191A3 (en) 1985-03-16 1991-12-17 Antiviral nucleosides
DK199102026A DK175122B1 (da) 1985-03-16 1991-12-18 Farmaceutisk præparat omfattende et farmaceutisk acceptabelt derivat af 3'azido-3'-desoxythymidin samt fremgangsmåde til fremstilling deraf
DK199102027A DK175192B1 (da) 1985-03-16 1991-12-18 Farmaceutisk præparat med indhold af 3'-azido-3'-desoxythymidin som aktiv ingrediens samt 3'-azido-3'-desoxythymidin til anvendelse mod en human retrovirusinfektion
CA000616284A CA1340519C (en) 1985-03-16 1992-01-13 Antiviral nucleosides
US08/005,405 US5643891A (en) 1985-03-16 1993-02-26 Treatment of viral infections
LV950243A LV5724B4 (lv) 1985-03-16 1995-08-04 Nukleozidi ar pretvirusu ipasibam
HK164395A HK164395A (en) 1985-03-16 1995-10-19 Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections
CY188996A CY1889A (en) 1985-03-16 1996-11-22 Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections
US08/882,888 US5885957A (en) 1985-03-16 1997-06-26 Treatment of HTLV-I infections
US08/889,254 US5877163A (en) 1985-03-16 1997-07-10 Treatment of human viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858506869A GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound

Publications (1)

Publication Number Publication Date
GB8506869D0 true GB8506869D0 (en) 1985-04-17

Family

ID=10576117

Family Applications (1)

Application Number Title Priority Date Filing Date
GB858506869A Pending GB8506869D0 (en) 1985-03-16 1985-03-16 Antiviral compound

Country Status (3)

Country Link
JP (1) JPS61257925A (enrdf_load_stackoverflow)
GB (1) GB8506869D0 (enrdf_load_stackoverflow)
ZA (1) ZA861933B (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4916122A (en) 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US5190926A (en) 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
JPS63250396A (ja) * 1987-04-03 1988-10-18 Taiho Yakuhin Kogyo Kk ３′−アジド−３′−デオキシチミジン誘導体
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4841039A (en) 1986-05-01 1989-06-20 Emory University 2',3'-dideoxy-5-substituted uridines and related compounds as antiviral agents
US4916122A (en) 1987-01-28 1990-04-10 University Of Georgia Research Foundation, Inc. 3'-Azido-2',3'-dideoxyuridine anti-retroviral composition
US5190926A (en) 1987-01-28 1993-03-02 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxypyrimidines and related compounds as antiviral agents

Also Published As

Publication number Publication date
JPH047726B2 (enrdf_load_stackoverflow) 1992-02-12
JPS61257925A (ja) 1986-11-15
ZA861933B (en) 1987-10-28

Similar Documents

Publication Publication Date Title
GR860712B (en) Antiviral compounds
PT82486B (en) Antiviral compounds
EP0159264A3 (en) Antiviral compounds
GB8501999D0 (en) Compounds
GB8606206D0 (en) Work-step attachment
GB8512330D0 (en) Antiviral compounds
GB2178740B (en) Alkylcarbamoyloxymethylcephem compounds
GB2203433B (en) Trizinyl compounds
JPS6445371A (en) Antiviral compound
GB8506869D0 (en) Antiviral compound
GB2170200B (en) Acylaminoalkanoyl compounds
JPS6475458A (en) Perfluoroalkylnaphthalene compound
GB8523881D0 (en) Antiviral compounds
GB8511774D0 (en) Antiviral compounds
DE3667058D1 (en) Antiviral compounds
GB2183236B (en) Carbamoyloxymethylalkylcarbapenem compounds
GB8603719D0 (en) Antiviral compounds
GB8603450D0 (en) Antiviral compounds
GB8503358D0 (en) Compounds
GB2175586B (en) Mycotrienin-related compounds
GB8511222D0 (en) Antiviral compounds
GB8511225D0 (en) Antiviral compounds
GB8511224D0 (en) Antiviral compounds
GB8523879D0 (en) Antiviral compounds
IE850918L (en) Antiviral compounds